-
-
-
-
-
-
-
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
-
-
-
-
-
-
-
Edwards Lifesciences Reports Second Quarter Results
-
-
-
-
-
-
-
Lead Plaintiff Deadline on December 13, 2024 for EW Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
-
-
-
-
-
-
-
Piper Sandler Reiterates Neutral Rating on Edwards Lifesciences (EW)
-
-
-
-
-
-
-
Becton Dickinson (BDX) to Acquire Edwards Lifesciences' (EW) Critical Care Product Group for $4.2B Cash
-
-
-
-
-
-
-
Edwards Lifesciences Reports Fourth Quarter Results
-
-
-
-
-
-
-
Edwards Lifesciences (EW) Reaffirms FY19 Guidance, Offers FY20 Guidance at Investor Conf.
-
1,154,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

